Roxanne Liu

RT @GeniusWu: Chinese start-ups scramble for alternatives to SVB https://t.co/PZ79EOxD3k great team work w/ Sam Shen @Selena_Li_QW @yanchun…

RT @GeniusWu: Exclusive: Chinese chip designer Unisoc seeks to raise $1.5 bln in private funding -sources https://t.co/0Mlmzdicpy great te…

RT @GeniusWu: China's open borders and push to stoke economy may revive dealmaking, advisers say https://t.co/AjxxQH7TRQ good work by @murd…

China has given about 56% of its 1.41 billion population a booster dose using domestic shots. Many people were boosted with the same product as their primary series, despite growing evidence that some mix-and-max strategies would likely achieve higher antibody levels.

Reuters @Reuters

CanSinoBIO's inhaled COVID booster stronger against BA.1 Omicron subvariant than Sinovac shot https://t.co/L16OBqpwQW https://t.co/j6mG0qyChM

RT @Reuters: Bavarian Nordic monkeypox vaccine wins EU approval https://t.co/HLr8QMRTTG https://t.co/6KtNrBW4QN

It is difficult for healthy women in China to access assisted-birth tech to delay their childbearing. National rules allow such methods only for medical issues, such as treating infertility or preserving the fertility of people before going through certain therapies.

Reuters @Reuters

In a landmark case of a woman fighting for her reproductive rights in China, Teresa Xu lost a court challenge seeking to freeze her eggs. The case highlights concerns about a lack of technology options for Chinese people considering delaying parenthood https://t.co/PbFJVlhL1b https://t.co/YGpsUk7gM8

RT @Reuters: Shionogi sinks in Tokyo trade after panel again delays COVID pill approval https://t.co/9hiAH4E7ZQ https://t.co/1xSSy6jrbg

At this point there is no major cause for concern while ongoing surveillance is important, says Federation University Australia professor Andrew Greenhill. O139 has been detected in other countries and large cholera outbreaks are unlikely in locations with adequate sanitation.

Reuters @Reuters

In China's Wuhan, cholera-causing bacteria in turtles strikes nerve https://t.co/T9C8CdxSVt https://t.co/99j7IQMcf0

RT @Reuters: Although there is no need for mass vaccination currently, countries should take quick steps to contain the spread of monkeypox…

RT @Reuters_Health: A handful of cases of monkeypox have now been reported or are suspected in the United Kingdom, Portugal and Spain. http…

RT @Reuters: GE unit boosts medical dye output as China COVID lockdown cuts supplies https://t.co/6m5cmDh7vP https://t.co/30Mri76svG

RT @Reuters: China perseveres with mRNA COVID shot development amid Omicron, commercial uncertainty https://t.co/3ioFbgZNOn https://t.co/7t…

From next week, a Phase III trial for Walvax's ARCoV mRNA vaccine candidate will shift its focus from recruiting more participants to identifying potential COVID cases for data analysis. The trial has recruited most of the 28,000 participants planned https://t.co/LfdUj0OzPx

RT @Reuters: China's Henan adds COVID curbs as cases rise, Xian official apologises https://t.co/oJ0oL1KGg0 https://t.co/ykThpjTwVv

Some residents are anxious to know when they can next stock up on necessities, as Xian city barred people from going out to shop during a testing round that started on Monday. Officials had said shopping could resume in certain areas after testing, but didn't say exactly when

Reuters @Reuters

China local symptomatic COVID cases rise for a 4th day as Xian outbreak expands https://t.co/eMoxTBxt8u https://t.co/u3Yaj786Sz

RT @Reuters: K-pop star Suga tests positive for COVID-19 after BTS return from U.S. https://t.co/x0bIGEcbnE https://t.co/EcfJHebN09

The shot reduced the risk of symptomatic COVID by 57.5% for vaccinated people v.s. the unvaccinated. The study did not look at how recent variants such as Delta and Omicron would affect the vaccine's effectiveness.

Reuters @Reuters

China CanSinoBIO's vaccine 57.5% effective against COVID in Phase III trial-study https://t.co/q4DyXAoqXk https://t.co/yOxdZJ47Gg